Reference
·Primary source
FDA cannabis medical-grow GAP and GMP licensees 2024
~80-120 operations
Active Thai FDA-registered cannabis indoor medical-grow operations under GAP or GMP licensing in 2024. Base case projects ~250-350 by 2027 as recriminalisation of recreational use redirects capex into medical-only facilities.
Figure in context
Active Thai FDA-registered cannabis indoor medical-grow operations under GAP or GMP licensing in 2024. Base case projects ~250-350 by 2027 as recriminalisation of recreational use redirects capex into medical-only facilities.
Active Thai FDA-registered cannabis indoor medical-grow operations under GAP or GMP licensing in 2024. Base case projects ~250-350 by 2027 as recriminalisation of recreational use redirects capex into medical-only facilities.
Time scope
FY2024
Source basis
Primary source
Interpretation notes
What this tells you
Active Thai FDA-registered cannabis indoor medical-grow operations under GAP or GMP licensing in 2024. Base case projects ~250-350 by 2027 as recriminalisation of recreational use redirects capex into medical-only facilities.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thai CEA and vertical-farm market 2027F
Insight derivation from BOI Section 8, BIOTEC pilot, SCB EIC precision-ag outlook, Grand View global benchmark
Commercial CEA and vertical-farm sites 2024
Insight derivation from BOI Section 8 disclosures, operator press, BIOTEC pilot directory
Medical-grow share of 2027 CEA market
Insight derivation from FDA licensee curve, BOI disclosures, operator triangulation
Imported LED share of new CEA builds
Signify case studies, Heliospectra disclosures, SCB EIC precision-ag outlook
kWh per kilogram leafy-green CEA benchmark
Insight derivation from operator disclosures, ERC tariff schedule, Priva and Signify CEA benchmarks
CapEx per square metre, multi-tier vertical CEA
Insight derivation from BOI Section 8 disclosures, operator press, Priva and Signify build benchmarks